These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
528 related articles for article (PubMed ID: 19168191)
1. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjögren's syndrome. Morozumi S; Kawagashira Y; Iijima M; Koike H; Hattori N; Katsuno M; Tanaka F; Sobue G J Neurol Sci; 2009 Apr; 279(1-2):57-61. PubMed ID: 19168191 [TBL] [Abstract][Full Text] [Related]
2. Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjögren's syndrome: a national multicentric retrospective study. Rist S; Sellam J; Hachulla E; Sordet C; Puéchal X; Hatron PY; Benhamou CL; Sibilia J; Mariette X; Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1339-44. PubMed ID: 21584943 [TBL] [Abstract][Full Text] [Related]
3. [Two distinct types of neuropathy associated with Sjögren's syndrome developed in one patient. The importance of the selection of an appropriate therapeutic regimen]. Noguchi Y; Tsuchiyama T; Matsumoto T; Fujigasaki H; Inaba A; Yokota T; Kanda T; Mizusawa H Rinsho Shinkeigaku; 2003 Sep; 43(9):539-43. PubMed ID: 14727559 [TBL] [Abstract][Full Text] [Related]
4. Differential response to intravenous immunoglobulin (IVIg) therapy among multifocal and polyneuropathy types of painful diabetic neuropathy. Kawagashira Y; Watanabe H; Morozumi S; Iijima I; Koike H; Hattori N; Sobue G J Clin Neurosci; 2010 Aug; 17(8):1003-8. PubMed ID: 20627580 [TBL] [Abstract][Full Text] [Related]
5. Pure sensory neuropathy in primary Sjögren's syndrome. Longterm prospective followup and review of the literature. Font J; Ramos-Casals M; de la Red G; Pou A; Casanova A; García-Carrasco M; Cervera R; Molina JA; Valls J; Bové A; Ingelmo M; Graus F J Rheumatol; 2003 Jul; 30(7):1552-7. PubMed ID: 12858457 [TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sjögren's syndrome. Kizawa M; Mori K; Iijima M; Koike H; Hattori N; Sobue G J Neurol Neurosurg Psychiatry; 2006 Aug; 77(8):967-9. PubMed ID: 16844955 [TBL] [Abstract][Full Text] [Related]
7. Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjögren's syndrome. Wakasugi D; Kato T; Gono T; Ito E; Nodera H; Kawaguchi Y; Yamanaka H; Hara M Mod Rheumatol; 2009; 19(4):437-40. PubMed ID: 19458906 [TBL] [Abstract][Full Text] [Related]
17. Small nerve fibre dysfunction in a patient with Sjögren's syndrome. Neurophysiological and morphological confirmation. Denislic M; Meh D; Popovic M; Kos-Golja M Scand J Rheumatol; 1995; 24(4):257-9. PubMed ID: 7481594 [TBL] [Abstract][Full Text] [Related]
18. [Cyclophosphamide-responsive subclinical Sjögren's syndrome in a patient with initial peripheral and central nervous system involvement]. Yamanishi Y; Taooka Y; Mukuzono H; Aoi K; Ishibe Y; Yamana S Ryumachi; 1994 Jun; 34(3):633-8. PubMed ID: 8052929 [TBL] [Abstract][Full Text] [Related]
19. Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome. Tuisku IS; Konttinen YT; Konttinen LM; Tervo TM Exp Eye Res; 2008 Jun; 86(6):879-85. PubMed ID: 18436208 [TBL] [Abstract][Full Text] [Related]
20. Peripheral neuropathies in Sjögren's syndrome: a critical update on clinical features and pathogenetic mechanisms. Pavlakis PP; Alexopoulos H; Kosmidis ML; Mamali I; Moutsopoulos HM; Tzioufas AG; Dalakas MC J Autoimmun; 2012 Aug; 39(1-2):27-33. PubMed ID: 22318209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]